Search results - 4 results

Direct impact of COVID-19 by estimating disability-adjusted life years at national level in France in 2020

post-acute consequences, in 28 days (baseline) up to 140 days, following the initial infection. METHODS: National mortality, COVID-19 screening, and hospital admission data were used to calculate DALY s based ...

Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.

lung-transplanted (28.6; 95% CI: 22.7-35.5) non-lung-transplanted pwCF (16.6; 95% CI: 15.4-17.8) (p≤0.001). SARS-CoV-2 infection caused symptomatic illness in 75.7%. Factors associated with symptomatic SARS-CoV-2 ...

Insights into the association of ACEIs/ARBs use and COVID-19 prognosis: a multistate modelling study of nationwide hospital surveillance data from Belgium.

patients transferred to ICU admission, no evidence of an association between ACEI s/ ARB s’ use and recovery (HR 1.16, 95% CI 0.97 to 1.38, p=0.098) or in-hospital death (HR 0.91, 95% CI 0.73 to 1.12, ...

Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.

characterise the impact of acute SARS-CoV-2 infection in people with cystic fibrosis and investigate factors associated with severe outcomes. Methods Data from 22 countries prior to 13 December 2020 and the ...

QR code

QR code for this page URL